Twin Tree Management, LP Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Twin Tree Management, LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $14.7 Million - $17.3 Million	14,400 New	14,400 $15.1 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $4.17 Million - $4.89 Million	-7,000 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $1.63 Million - $2.01 Million	-3,000 Reduced 30.0%	7,000 $4.42 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $11.4 Million - $14.5 Million	-23,800 Reduced 70.41%	10,000 $4.83 Million
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $39 Million - $48.6 Million	-123,400 Reduced 78.5%	33,800 $11.6 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $29.5 Million - $38.7 Million	82,300 Added 109.88%	157,200 $59.1 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $32.3 Million - $37.7 Million	74,900	74,900 $33.5 Million

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.